Loading clinical trials...

A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types | Clinical Trials | Clareo Health

UNKNOWNNCT05907447

A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types

The aim of this study is to retrospectively collect clinical information on patients with extranodal or rare lymphomas, and to explore the best treatment strategy for these lymphomas in the real-world...

Lead sponsor: Ruijin Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Weili Prof. Zhao

CONTACT

+862164370045 [email protected]

Pengpeng Prof. Xu

CONTACT

+862164370045 [email protected]

Related studies

RECRUITINGPhase 1/2

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

NCT06395103 · B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, and more

RECRUITINGPhase 2

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

NCT04728893 · Hematologic Malignancies, Waldenstroms Macroglobulinaemia, and more

RECRUITINGPhase 3

A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

NCT05100862 · Relapsed/Refractory Follicular Lymphoma, Marginal Zone Lymphoma

RECRUITINGPhase 1/2

A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer

NCT06678659 · Unresectable, Locally Advanced, and more

RECRUITINGPhase 3

International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma

NCT04043494 · Lymphoblastic Lymphoma, Childhood

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 18, 2023Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment10,000

Start dateJul 2023

Last updatedJun 18, 2023

Condition

Lymphoma Extranodal Lymphoma Diffuse Large B Cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma+4 more

Locations shown

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Shanghai

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 18, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions